DC Funds, LP Q2 2022 holdings

$7.25 Million is the total value of DC Funds, LP's 3 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
VACC  VACCITECH PLCads$2,858
-14.4%
642,2040.0%39.43%
-9.1%
HOWL  WEREWOLF THERAPEUTICS INC$2,409
-7.1%
589,1020.0%33.24%
-1.3%
 TSCAN THERAPEUTICS INC$1,981
+12.3%
630,0000.0%27.33%
+19.2%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Dean L. Wilde II — Chair, CEO and Managing Director

Compare quarterly holdings

Export DC Funds, LP's holdings

EDGAR filings